Laura Vogelsang

Laura Vogelsang serves as an Assistant Professor in the Department of Nursing within the Faculty of Health Sciences at the University of Lethbridge, where she focuses on advancing nursing education through innovative pedagogical frameworks and clinical simulation methodologies. Her academic role integrates teaching excellence with scholarship that directly impacts nursing practice and faculty development.

Her research program centers on the Scholarship of Teaching and Learning, with specialized expertise in Digital Health applications, Virtual Reality for clinical training, Succession Planning in academic nursing, and Dementia Care education. She develops evidence-based tools like the PREP mnemonic for clinical preparation and WRAP feedback model to enhance student competencies in high-stakes bedside environments, emphasizing safety and reflective practice.

Analysis of her publication trajectory (2014-2022) reveals progressive integration of technology in nursing education: evolving from faculty succession planning to simulation-based learning, then incorporating virtual reality for caregiver training in dementia contexts. This demonstrates a clear shift toward immersive digital solutions for complex clinical challenges, particularly in safety risk identification and interprofessional skill development.

Scientific Awards:

• No awards, fellowships, or medals were documented in source materials.

While specific student advisees aren't listed, her publications on student-created exams and reflective writing indicate active mentorship in curriculum development. The VR caregiver project featured by Lethbridge College suggests collaborative grant activity, though specific funding sources aren't detailed in the text.

Dr. Vogelsang collaborates on interdisciplinary health technology initiatives, notably developing virtual reality experiences for dementia caregivers. This positions her within innovation teams exploring how immersive simulations can bridge educational theory with real-world clinical demands, particularly for high-risk patient populations.